Renjiang Kong

755 total citations · 1 hit paper
29 papers, 585 citations indexed

About

Renjiang Kong is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Renjiang Kong has authored 29 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biomedical Engineering, 19 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Renjiang Kong's work include Nanoplatforms for cancer theranostics (27 papers), Photodynamic Therapy Research Studies (18 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Renjiang Kong is often cited by papers focused on Nanoplatforms for cancer theranostics (27 papers), Photodynamic Therapy Research Studies (18 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Renjiang Kong collaborates with scholars based in China. Renjiang Kong's co-authors include Hong Cheng, Shiying Li, Rongrong Zheng, Linping Zhao, Chu‐Yu Huang, Xiaona Rao, Xiyong Yu, Ali Chen, Yang Ni and Jiaqi Huang and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Renjiang Kong

29 papers receiving 578 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts

2024 47 citations Ziwen Qiu, Yingtao Zhong et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renjiang Kong China	15	445	183	174	133	120	29	585
Ningyue Yu China	16	536 1.2×	104 0.6×	165 0.9×	122 0.9×	137 1.1×	29	661
Fu‐An Deng China	13	474 1.1×	195 1.1×	141 0.8×	88 0.7×	157 1.3×	23	550
Mengbin Ding China	16	524 1.2×	95 0.5×	158 0.9×	126 0.9×	172 1.4×	31	670
Xiaoyi Yin China	12	384 0.9×	135 0.7×	191 1.1×	97 0.7×	122 1.0×	33	683
Rundi Song China	7	413 0.9×	196 1.1×	256 1.5×	268 2.0×	79 0.7×	10	707
Yujun Cai China	11	355 0.8×	82 0.4×	128 0.7×	168 1.3×	96 0.8×	13	480
Wen Ma China	13	273 0.6×	93 0.5×	191 1.1×	135 1.0×	100 0.8×	32	552
Yawen Ding China	10	328 0.7×	95 0.5×	165 0.9×	67 0.5×	143 1.2×	23	512
Wenshe Sun China	12	413 0.9×	175 1.0×	235 1.4×	80 0.6×	178 1.5×	21	689
Hengjing Yi China	7	508 1.1×	140 0.8×	120 0.7×	81 0.6×	138 1.1×	8	557

Countries citing papers authored by Renjiang Kong

Since Specialization

Citations

This map shows the geographic impact of Renjiang Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renjiang Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renjiang Kong more than expected).

Fields of papers citing papers by Renjiang Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renjiang Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renjiang Kong. The network helps show where Renjiang Kong may publish in the future.

Co-authorship network of co-authors of Renjiang Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Renjiang Kong. A scholar is included among the top collaborators of Renjiang Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renjiang Kong. Renjiang Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yanmei, Xinyu Li, Yan Ni, et al.. (2024). Cascade STING activation of a ternary immunostimulant for colorectal cancer eradication via photodynamic DNA damage and T regulatory cell inhibition. Chemical Engineering Journal. 497. 154849–154849. 2 indexed citations

Zhang, Wei, Qianqian Liu, Yang Ni, et al.. (2024). Tumor Homing Chimeric Peptide Rhomboids to Improve Photodynamic Performance by Inhibiting Therapy‐Upregulated Cyclooxygenase‐2. Small. 20(28). e2309882–e2309882. 5 indexed citations

Zhong, Yingtao, Ziwen Qiu, Yanmei Li, et al.. (2024). Nutrients deprivation of biomimetic nanozymes for cascade catalysis triggered and oxidative damage induced tumor eradication. Chinese Chemical Letters. 36(3). 109846–109846. 2 indexed citations

Li, Xinyu, et al.. (2024). Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis. ACS Applied Materials & Interfaces. 16(17). 21709–21721. 2 indexed citations

Qiu, Ziwen, Yingtao Zhong, Zhen‐Ming Lu, et al.. (2024). Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts. ACS Nano. 18(13). 9713–9735. 47 indexed citations breakdown →

Qiu, Ziwen, Zhen‐Ming Lu, Jiaqi Huang, et al.. (2023). Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment. Biomaterials. 303. 122392–122392. 23 indexed citations

Li, Yanmei, Xinyu Li, Jiaqi Huang, et al.. (2023). Self‐Delivery O₂‐Ecomonizer to Reverse Antiapoptosis of Hypoxic Tumor for Enhanced Photodynamic Therapy. Advanced Therapeutics. 6(4). 1 indexed citations

Chen, Shaoyi, Linping Zhao, Chu‐Yu Huang, et al.. (2023). Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy. Acta Biomaterialia. 158. 599–610. 21 indexed citations

Zhao, Linping, Xiaona Rao, Rongrong Zheng, et al.. (2023). Targeting glutamine metabolism with photodynamic immunotherapy for metastatic tumor eradication. Journal of Controlled Release. 357. 460–471. 27 indexed citations

10.

Huang, Jiaqi, Renjiang Kong, Yanmei Li, et al.. (2023). Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters. 35(8). 109254–109254. 3 indexed citations

11.

Liu, Yibin, Yang Ni, Renjiang Kong, et al.. (2023). Drug induced mitochondria dysfunction to enhance photodynamic therapy of hypoxic tumors. Journal of Controlled Release. 358. 654–666. 16 indexed citations

12.

Li, Xinyu, Yanmei Li, Renjiang Kong, et al.. (2023). Feedback-Elevated Antitumor Amplifier of Self-Delivery Nanomedicine by Suppressing Photodynamic Therapy-Caused Inflammation. ACS Applied Bio Materials. 6(7). 2816–2825. 6 indexed citations

13.

Zhao, Linping, Xiaona Rao, Rongrong Zheng, et al.. (2023). Carrier-Free Nano-PROTACs to Amplify Photodynamic Therapy Induced DNA Damage through BRD4 Degradation. Nano Letters. 23(13). 6193–6201. 38 indexed citations

14.

Zhao, Linping, Xiaona Rao, Chu‐Yu Huang, et al.. (2022). Epigenetic reprogramming of carrier free photodynamic modulator to activate tumor immunotherapy by EZH2 inhibition. Biomaterials. 293. 121952–121952. 15 indexed citations

15.

Li, Yanmei, Xinyu Li, Jiaqi Huang, et al.. (2022). Carrier free nanomedicine to reverse anti-apoptosis and elevate endoplasmic reticulum stress for enhanced photodynamic therapy. Acta Biomaterialia. 152. 507–518. 11 indexed citations

16.

Deng, Fu‐An, Rongrong Zheng, Renjiang Kong, et al.. (2022). Ce6- and Bez235-Based Nanomedicine for Chemo-/Photodynamic Combination Therapy of Tumors. ACS Applied Nano Materials. 5(7). 9277–9285. 8 indexed citations

17.

Zhao, Linping, Chu‐Yu Huang, Rongrong Zheng, et al.. (2022). Photodynamic amplified immune checkpoint-blockade therapy of self-delivery bioregulator via epigenetic reprogramming. Chemical Engineering Journal. 453. 139729–139729. 8 indexed citations

18.

Zheng, Rongrong, Linping Zhao, Renjiang Kong, et al.. (2022). Photodynamic therapy initiated immunotherapy of self-delivery re-educator by inducing immunogenic cell death and macrophage polarization. Chemical Engineering Journal. 435. 134783–134783. 32 indexed citations

19.

Zhao, Linping, Shaoyi Chen, Rongrong Zheng, et al.. (2022). Photodynamic Therapy Initiated Ferrotherapy of Self-Delivery Nanomedicine to Amplify Lipid Peroxidation via GPX4 Inactivation. ACS Applied Materials & Interfaces. 14(48). 53501–53510. 19 indexed citations

20.

Li, Xinyu, Fu‐An Deng, Rongrong Zheng, et al.. (2021). Carrier Free Photodynamic Synergists for Oxidative Damage Amplified Tumor Therapy. Small. 17(40). e2102470–e2102470. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact